Nexalin Technology (NXL) Research & Development (2024 - 2026)
Nexalin Technology (NXL) recorded quarterly Research & Development of $346382.0 in Q1 2026, up 53.99% quarter-over-quarter from $224940.0 in Q4 2025, and down 14.74% on a YoY basis from $406288.0 in Q1 2025.
Nexalin Technology (NXL) Research & Development (2024 - 2026) Analysis & Trends
Nexalin Technology's Research & Development history runs 3 years deep, the most recent figure standing at $346382.0 for Q1 2026.
- In Q1 2026, Research & Development fell 14.74% year-over-year to $346382.0; the TTM figure through Mar 2026 stood at $1.0 million (down 31.37% YoY), while the FY2025 annual figure was $1.1 million, down 9.02% from the prior year.
- Research & Development was $346382.0 for Q1 2026 at Nexalin Technology, up from $224940.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $737242.0 in Q4 2024 to a low of $105668.0 in Q1 2024.
- Historically, Research & Development has averaged $291198.8 across 3 years, with a median of $225774.0 in 2025.
- Biggest YoY gain for Research & Development was 284.49% in 2025; the steepest drop was 69.49% in 2025.
- A 3-year view of Research & Development shows it stood at $737242.0 in 2024, then sank by 69.49% to $224940.0 in 2025, then soared by 53.99% to $346382.0 in 2026.
- The last three Research & Development figures came in at $346382.0 (Q1 2026), $224940.0 (Q4 2025), and $226520.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 346,382.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 346,382.00 |
| Dec 31, 2025 | 224,940.00 |
| Sep 30, 2025 | 226,520.00 |
| Jun 30, 2025 | 225,774.00 |
| Mar 31, 2025 | 406,288.00 |
| Dec 31, 2024 | 737,242.00 |
| Sep 30, 2024 | 178,565.00 |
| Jun 30, 2024 | 169,410.00 |
| Mar 31, 2024 | 105,668.00 |